Myasthenia Gravis: A Systematic Review

Area of Science:

• Neurology
• Immunology
• Rare Diseases

Background:

• Myasthenia gravis (MG) is the most common disorder affecting the neuromuscular junction.
• It is an autoimmune condition characterized by antibodies against the acetylcholine receptor (AChR), leading to fatigable muscle weakness.
• Potential triggers include infections, stress, surgery, and thymus gland anomalies.

Purpose of the Study:

• To provide comprehensive information on Myasthenia gravis (MG).
• To aid in the recognition of MG symptoms for prompt treatment initiation.
• To reduce disease progression and prevent complications.

Main Methods:

• Diagnosis relies on clinical evidence, including patient history and physical examination for fluctuating muscle weakness.
• Complementary diagnostic procedures and laboratory techniques confirm synaptic dysfunction and its characteristics.
• Review of existing literature on MG pathophysiology, diagnosis, and treatment.

Main Results:

• Ocular symptoms are common initial manifestations, with most patients experiencing symptom exacerbation.
• Thymic hyperplasia (enlarged thymus) is often associated with MG, suggesting a potential causal link.
• Early-onset MG (EOMG) is more prevalent in women, while late-onset MG (LOMG) is more common in men.

Conclusions:

• Early diagnosis and effective treatments have significantly improved outcomes for MG patients.
• Current immunomodulatory therapies can cause side effects due to immune suppression.
• Increased awareness among healthcare providers is essential for managing this rare but treatable condition.